Compositions and methods of altering the electric impedance to an alternating electric field
Disclosed are methods of altering the electric impedance to an alternating electric field in a target site of a subject, comprising introducing a nanoparticle to a target site in the subject; and applying an alternating electric field to the target site of the subject, wherein the electric impedance in the target site of the subject to the alternating current is altered. Disclosed are methods for improving transport of a nanoparticle across a cell membrane of a cell, the method comprising applying an alternating electric field to the cell for a period of time, wherein application of the alternating electric field increases permeability of the cell membrane; and introducing the nanoparticle to the cell, wherein the increased permeability of the cell membrane enables the nanoparticle to cross the cell membrane. Disclosed are methods of imaging a cancer cell, the method comprising applying a first alternating electric field at a first frequency to the cancer cell for a first period of time, wherein application of the first alternating electric field at the first frequency to the cancer cell for the first period of time increases permeability of cell membranes of the cancer cell; introducing a nanoparticle to the cancer cell, wherein the increased permeability of the cell membranes enables the nanoparticle to cross the cancer cell membrane; and imaging the cancer cell.
1. A method of altering the electric impedance to an alternating electric field in a tumor target site of a subject, comprising
a. introducing a conductive nanoparticle to a tumor target site in the subject; and
b. applying an alternating electric field to the tumor target site of the subject,
wherein the electric impedance in the tumor target site of the subject to the alternating current is altered,
wherein the altered electric impedance in the tumor target site of the subject to the alternating current results in an increased mitotic effect of the alternating electric field in the tumor target site.
2. The method of claim 1 , wherein the current density and/or power loss density in the tumor target site of the subject to the alternating current is altered.
3. The method of claim 1 , wherein the impedance in the tumor target site is lowered.
4. The method of claim 1 , wherein the conductivity in the tumor target site is increased.
5. The method of claim 1 , further comprising: introducing a non-conductive nanoparticle to a site adjacent to the tumor target site in the subject; and applying an alternating electric field to the site adjacent to the tumor target site of the subject.
6. The method of claim 5 , wherein the current density and/or power loss density in the tumor target site of the subject to the alternating current is altered.
7. The method of claim 5 , wherein the conductivity is decreased in the site adjacent to the tumor target site.
8. The method of claim 5 , wherein the impedance in the site adjacent to the tumor target site is increased.
9. The method of claim 5 , wherein the impedance in the tumor target site is decreased.
10. The method of claim 5 , wherein the non-conductive nanoparticle is not a ferroelectric nanoparticle.
11. The method of claim 5 , wherein the impedance in the tumor target site is increased.
12. The method of claim 5 , wherein the conductivity in the tumor target site is decreased.
13. The method of claim 5 , wherein the alternating electric field is a tumor-treating field.
14. The method of claim 5 , wherein the nanoparticles are nanoparticles that increase tissue permittivity.